Well, looks like MMs have had their fun for now. With convention (see below) and FDA approval coming- and 2 months of "no news" waiting period about to end- we are likely to finally get to $9-10 here by Christmas. Check this article (which was omitted from your regular news service) out:
Techvest to Host Investment Forum for Tissue Repair, Replacement and Regeneration
BusinessWire, Monday, October 11, 1999 at 08:14
NEW YORK--(BW HealthWire)--Oct. 11, 1999--Techvest, LLC, a leading investment research, consulting and investment banking firm specializing in the biotechnology and biomedical sectors, will be hosting the Tissue Repair, Replacement and Regeneration Conference in October. The event will feature 50 of the leading companies in the above sectors, both public and private, presenting on their latest developments and strategic plans moving forward.
The conference is taking place on October 27-28th at the New York Marriott East Side Hotel, 525 Lexington Avenue, New York, NY 10017.
The conference is a valuable opportunity to meet the major industry players and to gain insight into the most promising investment opportunities in these emerging areas, which will lead to innovative patient care over the next decade. *T
Presenting Companies
--------------------
Aastrom Biosciences (NASDAQ:ASTM) Musculoskeletal Transplant Acorda Therapeutics (Private) Foundation (Not-for-profit) Advanced Tissue Sciences (NASDAQ:ATIS) Nexia Biotechnologies (Private) Anika Therapeutics (NASDAQ:ANIK) Novocell Company (Private) Biomatrix (NYSE:BXM) NeoTherapeutics (NASDAQ:NEOT) Circe BioMedical (Private) Ontogeny (Private) Co.don (Private) Organogenesis (AMEX:ORG) Collagenesis (Private) Organ Recovery Systems (Private) Creative BioMolecules (NASDAQ:CBMI) ... |
